Oral Answers to Questions

Kate Hollern Excerpts
Tuesday 1st September 2020

(3 years, 7 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

Yes. The direct provision of healthcare is of course devolved, but as the UK Health Secretary I take an interest in ensuring we have high quality healthcare right across the country. I am very happy to work with my colleagues in the Welsh Government on improving the delivery of services in the Betsi Cadwaladr health service. I wish the new chief executive all the very best. I am sure she will take the service, improve it and work with her colleagues in this House to make sure that the people of north Wales get the very best health services that they deserve.

Kate Hollern Portrait Kate  Hollern  (Blackburn)  (Lab)
- Hansard - -

Having used the coronavirus testing kit produced by Randox, which was awarded a £133 million contract by the Government, care homes in Blackburn were told that the kits were unsafe and re-tests should be carried out. As the Secretary of State knows, people in Blackburn have worked extremely hard to get the virus rates down. However, when care homes asked for replacement kits, they were informed that they had already received their quota and that no kits would be available until September. On the one hand the Government are saying, “Don’t use the kits” and on the other hand they are saying, “We have no kits to replace them with.” When will the Government reassure care homes in Blackburn that they will receive test kits regularly and, more importantly at this stage, the rapid results of those tests?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

In response to the last point, the turnaround time for test results is now the next day for almost every one. However, there has been a challenge, referred to just now and in a previous question, with the Randox kits. The test results from the Randox kits that were withdrawn were accurate. The challenge was that the Randox kits did not pass our very high and stringent standards; essentially they were not as clean as we would have wanted. I am informed by the clinicians that there is no evidence of any health threat from that, but of course we have to make sure that we protect people as much as possible. Hence, we had to withdraw the kits. As I said, we have a catch-up programme that is under way.